Some pharmacists already employ trained prescribers who are able to issue medicines on prescription. The latest changes may still require a consultation with a pharmacist, as is the case when the contraceptive pill is purchased over the counter.
The number of women taking HRT therapy fell dramatically after a major 2002 study linked it to an increased risk of breast cancer. Since then, evidence has been conflicting.
In 2015, NHS watchdogs said far more help should be offered to those suffering debilitating night sweats and hot flushes. Experts from the National Institute of Health and Care Excellence suggested at least twice as many women could benefit from HRT as were actually on it, saying far too many had been left in “unbearable” misery.
In 2019, a Lancet review said the therapy raised the risks of breast cancer by one third. It found that while the risk of breast cancer was 6.3 per cent for women aged between 50 and 69 who have not taken HRT, it rises to 8.3 per cent for those on the most common combination of HRT.
‘Really important for women – extremely welcome’
The medication works by boosting levels of the hormones oestrogen and progesterone, which are lower among women during the menopausal period.
Last year, a study found that taking hormone replacement therapy during the menopause does not increase the risk of dementia. However, staying on HRT long term was linked to a slight increase in the risk of Alzheimer’s.
The changes will mean pharmaceutical manufacturers can apply for reclassification of their products, allowing over-the-counter sale under the supervision of a qualified pharmacist.
They come as ministers prepare to extend rules that allow abortion pills to be taken at home. Since the start of the Covid pandemic, home abortions have been allowed in the first 10 weeks of pregnancy in legislation due to expire at the end of next month.
But the Telegraph understands that period will now be extended in a move likely to anger anti-abortion groups and some MPs.
Clare Murphy, the chief executive of the British Pregnancy Advisory Service, said: “Improving access to HRT as well as abortion and contraception is really important for women, so this is extremely welcome news.”
A Department of Health and Social Care spokesman said: “We understand that, for some women, menopause symptoms can have a significant impact on their quality of life, and we are committed to improving the care and support they receive.
“That’s why we’re developing the first ever government-led Women’s Health Strategy, informed by women’s lived experience. Menopause, including improving access to Hormone Replacement Therapy, will be a priority under the strategy.”
